SEARCH

SEARCH BY CITATION

REFERENCES

  • Andres V, Walsh K. 1996. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol 132: 657666.
  • Bothos J, Tuttle RL, Ottey M, Luca FC, Halazonetis TD. 2005. Human LATS1 is a mitotic exit network kinase. Cancer Res 65: 65686575.
  • Brook JD, Harley HG, Aburatani H, Stanton VP, Hudson T, Snell RG, Davies J, Shelbourne P, Buxton J, Jones J, Juvonen V, Johnson K, Harper PS, Shaw DJ, Housman DE. 1992. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 68: 799808.
  • Bush EW, Taft CS, Meixell GE, Perryman MB. 1996. Overexpression of myotonic dystrophy kinase in BC3H1 cells induces the skeletal muscle phenotype. J Biol Chem 271: 548552.
  • Bush EW, Helmke SM, Birnbaum RA, Perryman MB. 2000. Myotonic dystrophy protein kinase domains mediate localization, oligomerization, novel catalytic activity, and autoinhibition. Biochemistry 39: 84808490.
  • Carango P, Noble JE, Marks HG, Funanage VL. 1993. Absence of myotonic dystrophy protein kinase (DMPK) mRNA as a result of a triplet repeat expansion in myotonic dystrophy. Genomics 18: 340348.
  • Cho DH, Tapscott SJ. 2007. Myotonic dystrophy: emerging mechanisms for DM1 and DM2. Biochim Biophys Acta 1772: 195204.
  • Cooper ST, Maxwell AL, Kizana E, Ghoddusi M, Hardeman EC, Alexander IE, Allen DG, North KN. 2004. C2C12 co-culture on a fibroblast substratum enables sustained survival of contractile, highly differentiated myotubes with peripheral nuclei and adult fast myosin expression. Cell Motil Cytoskeleton 58: 200211.
  • Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, Kress W, Schneider C, Koch MC, Beilman GJ, Harrison AR, Dalton JC, Ranum LP. 2003. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 60: 657664.
  • Edgar BA. 2006. From cell structure to transcription: Hippo forges a new path. Cell 124: 267273.
  • Fardaei M, Rogers MT, Thorpe HM, Larkin K, Hamshere MG, Harper PS, Brook JD. 2002. Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum Mol Genet 11: 805814.
  • Friedman DL, Hejtmancik JF, Hope JN, Perryman MB. 1989. Developmental expression of creatine kinase isozymes in mammalian lens. Exp Eye Res 49: 445457.
  • Fu Y-H, Pizzuti A, Fenwick RG, King J, Rajnarayan S, Dunne PW, Dubel J, Nasser GA, Ashizawa T, de Jong P, Weiringa B, Korneluk RG, Perryman MB, Epstein HF, Caskey CT. 1992. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255: 12561258.
  • Furling D, Lemieux D, Taneja K, Puymirat J. 2001. Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts. Neuromuscul Disord 11: 728735.
  • Furling D, Lam le T, Agbulut O, Butler-Browne GS, Morris GE. 2003. Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy. Am J Pathol 162: 10011009.
  • Gregorio CC, Fowler VM. 1995. Mechanisms of thin filament assembly in embryonic chick cardiac myocytes: tropomodulin requires tropomyosin for assembly. J Cell Biol 129: 683695.
  • Hamburger V, Hamilton HL. 1951. A series of normal stages in the development of the chick embryo. J Morphol 88: 4992.
  • Harper PS. 2001. Myotonic dystrophy. London: WB Saunders.
  • Helmke SM, Lu SM, Harmon M, Glasford JW, Larsen TD, Kwok SC, Hodges RS, Perryman MB. 2006. Myotonic dystrophy protein kinase monoclonal antibody generation from a coiled-coil template. J Mol Recognit 19: 215226.
  • Ho TH, Bundman D, Armstrong DL, Cooper TA. 2005. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Hum Mol Genet 14: 15391547.
  • Huang Y, Wright CD, Merkwan CL, Baye NL, Liang Q, Simpson PC, O'Connell TD. 2007. An alpha1A-adrenergic-extracellular signal-regulated kinase survival signaling pathway in cardiac myocytes. Circulation 115: 763772.
  • Iida S, Hirota T, Morisaki T, Marumoto T, Hara T, Kuninaka S, Honda S, Kosai K, Kawasuji M, Pallas DC, Saya H. 2004. Tumor suppressor WARTS ensures genomic integrity by regulating both mitotic progression and G1 tetraploidy checkpoint function. Oncogene 23: 52665274.
  • Jansen G, Groenen PJ, Bachner D, Jap PH, Coerwinkel M, Oerlemans F, van den Broek W, Gohlsch B, Pette D, Plomp JJ, Molenaar PC, Nederhoff MG, van Echteld CJ, Dekker M, Berns A, Hameister H, Wieringa B. 1996. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nat Genet 13: 316324.
  • Joulia D, Bernardi H, Garandel V, Rabenoelina F, Vernus B, Cabello G. 2003. Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin. Exp Cell Res 286: 263275.
  • Justice RW, Zilian O, Woods DF, Noll M, Bryant PJ. 1995. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev 9: 534546.
  • Kahane N, Kalcheim C. 1998. Identification of early postmitotic cells in distinct embryonic sites and their possible roles in morphogenesis. Cell Tissue Res 294: 297307.
  • Kaliman P, Catalucci D, Lam JT, Kondo R, Gutierrez JC, Reddy S, Palacin M, Zorzano A, Chien KR, Ruiz-Lozano P. 2004. Myotonic dystrophy protein kinase (DMPK) phosphorylates phospholamban and regulates calcium uptake in cardiomyocyte sarcoplasmic reticulum. J Biol Chem 280: 80168021.
  • Kamradt MC, Chen F, Sam S, Cryns VL. 2002. The small heat shock protein alpha B-crystallin negatively regulates apoptosis during myogenic differentiation by inhibiting caspase-3 activation. J Biol Chem 277: 3873138736.
  • Kanadia RN, Johnstone KA, Mankodi A, Lungu C, Thornton CA, Esson D, Timmers AM, Hauswirth WW, Swanson MS. 2003. A muscleblind knockout model for myotonic dystrophy. Science 302: 19781980.
  • Kitzmann M, Fernandez A. 2001. Crosstalk between cell cycle regulators and the myogenic factor MyoD in skeletal myoblasts. Cell Mol Life Sci 58: 571579.
  • Krahe R, Ashizawa T, Abbruzzese C, Roeder E, Carango P, Giacanelli M, Funanage V, Siciliano M. 1995. Effect of myotonic dystrophy trinucleotide repeat expansion on DMPK transcription and processing. Genomics 28: 114.
  • Lathrop B, Olson E, Glaser L. 1985. Control by fibroblast growth factor of differentiation in the BC3H1 muscle cell line. J Cell Biol 100: 15401547.
  • Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP. 2001. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293: 864867.
  • Machida K, Ishibashi R, Hara T, Ohtsuka A, Hayashi K. 2003. Effects of corticosterone on Ca2+ uptake and myofibrillar disassembly in primary muscle cell culture. Biosci Biotechnol Biochem 67: 244249.
  • Maeda M, Taft CS, Bush EW, Holder E, Bailey WM, Neville H, Perryman MB, Bies RD. 1995. Identification, tissue-specific expression, and subcellular localization of the 80- and 71-kDa forms of myotonic dystrophy kinase protein. J Biol Chem 270: 2024620249.
  • Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, Neville C, Narang M, Barcelo J, O'Hoy K, Leblond S, Earle-Macdonald J, deJong PJ, Wieringa B, Korneluk RG. 1992. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science 255: 12531255.
  • Mankodi A, Urbinati CR, Yuan QP, Moxley RT, Sansone V, Krym M, Henderson D, Schalling M, Swanson MS, Thornton CA. 2001. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum Mol Genet 10: 21652170.
  • Menard C, Pupier S, Mornet D, Kitzmann M, Nargeot J, Lory P. 1999. Modulation of L-type calcium channel expression during retinoic acid-induced differentiation of H9C2 cardiac cells. J Biol Chem 274: 2906329070.
  • Morisaki T, Hirota T, Iida S, Marumoto T, Hara T, Nishiyama Y, Kawasuzi M, Hiraoka T, Mimori T, Araki N, Izawa I, Inagaki M, Saya H. 2002. WARTS tumor suppressor is phosphorylated by Cdc2/cyclin B at spindle poles during mitosis. FEBS Lett 529: 319324.
  • Morrone A, Pegoraro E, Angelini C, Zammarchi E, Marconi G, Hoffman E. 1997. RNA metabolism in myotonic dystrophy. J Clin Invest 99: 16911698.
  • Mounsey JP, Mistry DJ, Ai CW, Reddy S, Moorman JR. 2000. Skeletal muscle sodium channel gating in mice deficient in myotonic dystrophy protein kinase. Hum Mol Genet 9: 23132320.
  • Nicol RL, Frey N, Pearson G, Cobb M, Richardson J, Olson EN. 2001. Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J 20: 27572767.
  • O'Connell TD, Ni YG, Lin KM, Han H, Yan Z. 2003. Isolation and culture of adult mouse cardiac myocytes for signaling. AfCS Research Reports 1: 19.
  • Orengo JP, Chambon P, Metzger D, Mosier DR, Snipes GJ, Cooper TA. 2008. Expanded CTG repeats within the DMPK 3' UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy. Proc Natl Acad Sci U S A 105: 26462651.
  • Pagano M, Naviglio S, Spina A, Chiosi E, Castoria G, Romano M, Sorrentino A, Illiano F, Illiano G. 2004. Differentiation of H9c2 cardiomyoblasts: the role of adenylate cyclase system. J Cell Physiol 198: 408416.
  • Porrello A, Cerone MA, Coen S, Gurtner A, Fontemaggi G, Cimino L, Piaggio G, Sacchi A, Soddu S. 2000. p53 regulates myogenesis by triggering the differentiation activity of pRb. J Cell Biol 151: 12951304.
  • Puri PL, Medaglia S, Cimino L, Maselli C, Germani A, De Marzio E, Levrero M, Balsano C. 1997. Uncoupling of p21 induction and MyoD activation results in the failure of irreversible cell cycle arrest in doxorubicin-treated myocytes. J Cell Biochem 66: 2736.
  • Reddy S, Smith DB, Rich MM, Lefervich JM, Reilly P, Davis BM, Tran K, Rayburn H, Bronson R, Cros D, Balice-Gordon RJ, Housman D. 1996. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nat Genet 13: 325335.
  • Reddy S, Mistry DJ, Wang QC, Geddis LM, Kutchai HC, Moorman JR, Mounsey JP. 2002. Effects of age and gene dose on skeletal muscle sodium channel gating in mice deficient in myotonic dystrophy protein kinase. Muscle Nerve 25: 850857.
  • Sarkar PS, Han J, Reddy S. 2004. In situ hybridization analysis of Dmpk mRNA in adult mouse tissues. Neuromuscul Disord 14: 497506.
  • Sasagawa N, Kino Y, Takeshita Y, Oma Y, Ishiura S. 2003. Overexpression of human myotonic dystrophy protein kinase in Schizosaccharomyces pombe induces an abnormal polarized and swollen cell morphology. J Biochem (Tokyo) 134: 537542.
  • Shen X, Collier JM, Hlaing M, Zhang L, Delshad EH, Bristow J, Bernstein HS. 2003. Genome-wide examination of myoblast cell cycle withdrawal during differentiation. Dev Dyn 226: 128138.
  • Shiokawa D, Kobayashi T, Tanuma S. 2002. Involvement of DNase gamma in apoptosis associated with myogenic differentiation of C2C12 cells. J Biol Chem 277: 3103131037.
  • Simpson P. 1985. Stimulation of hypertrophy of cultured neonatal rat heart cells through an alpha 1-adrenergic receptor and induction of beating through an alpha 1- and beta 1-adrenergic receptor interaction. Evidence for independent regulation of growth and beating. Circ Res 56: 884894.
  • Taneja KL, McCurrach M, Schalling M, Housman D, Singer RH. 1995. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J Cell Biol 128: 9951002.
  • Tao W, Zhang S, Turenchalk GS, Stewart RA, St John MA, Chen W, Xu T. 1999. Human homologue of the Drosophila melanogaster lats tumour suppressor modulates CDC2 activity. Nat Genet 21: 177181.
  • Timchenko NA, Cai ZJ, Welm AL, Reddy S, Ashizawa T, Timchenko LT. 2001. RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J Biol Chem 276: 78207826.
  • Timchenko NA, Patel R, Iakova P, Cai ZJ, Quan L, Timchenko LT. 2004. Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis. J Biol Chem 279: 1312913139.
  • Walsh K, Perlman H. 1997. Cell cycle exit upon myogenic differentiation. Curr Opin Genet Dev 7: 597602.
  • Wang J, Pegoraro E, Menegazzo E, Gennarelli M, Hoop R, Angelini C, Hoffman E. 1995. Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation. Hum Mol Genet 4: 599606.
  • Wang J, Walsh K. 1996. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 273: 359361.
  • Wansink DG, Wieringa B. 2003. Transgenic mouse models for myotonic dystrophy type 1 (DM1). Cytogenet Genome Res 100: 230242.
  • Whiting EJ, Waring JD, Tamai K, Somerville MJ, Hincke M, Staines WA, Ikeda J-E, Korneluk RG. 1995. Characterization of myotonic dystrophy kinase (DMK) protein in human and rodent muscle and central nervous tissue. Hum Mol Genet 4: 10631072.
  • Yadava RS, Frenzel-McCardell CD, Yu Q, Srinivasan V, Tucker AL, Puymirat J, Thornton CA, Prall OW, Harvey RP, Mahadevan MS. 2008. RNA toxicity in myotonic muscular dystrophy induces NKX2–5 expression. Nat Genet 40: 6168.
  • Yang X, Yu K, Hao Y, Li DM, Stewart R, Insogna KL, Xu T. 2004. LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1. Nat Cell Biol 6: 609617.